Evaluation of Infective Property of Recombinant Prion Protein Amyloids in Cultured Cells Overexpressing Cellular Prion Protein
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dae-Hwan | - |
dc.contributor.author | Lee, Hye-Mi | - |
dc.contributor.author | Ryou, Chongsuk | - |
dc.date.accessioned | 2021-06-22T22:04:27Z | - |
dc.date.available | 2021-06-22T22:04:27Z | - |
dc.date.issued | 2014-12 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/21104 | - |
dc.description.abstract | Misfolded isoform of prion protein (PrP), termed scrapie PrP ( PrPSc), tends to aggregate into various fibril forms. Previously, we reported various conditions that affect aggregation of recombinant PrP into amyloids. Because amyloidogenesis of PrP is closely associated with transmissible spongiform encephalopathies such as Creutzfeldt-Jakob disease in humans, we investigated infectivity of recombinant PrP amyloids generated in vitro. Using cultured cell lines which overexpress cellular PrP of different species, we measured the level of de novo synthesized PrPSc in cells inoculated with recombinant mouse PrP amyloids. While PrP-overexpressing cells were susceptible to mouse-adapted scrapie prions used as the positive control, demonstrating the species barrier effect, infection with amyloids made of truncated recombinant PrP (PrP[89-230]) failed to form and propagate PrPSc even in the cells that express mouse cellular PrP. This suggests that infectivity of PrP amyloids generated in vitro is different from that of natural prions. Recombinant PrP (89-230) amyloids tested in the current study retain no or a minute level, if any, of prion infectivity. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한의학회 | - |
dc.title | Evaluation of Infective Property of Recombinant Prion Protein Amyloids in Cultured Cells Overexpressing Cellular Prion Protein | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3346/jkms.2014.29.12.1604 | - |
dc.identifier.scopusid | 2-s2.0-84938297787 | - |
dc.identifier.wosid | 000346507200004 | - |
dc.identifier.bibliographicCitation | Journal of Korean Medical Science, v.29, no.12, pp 1604 - 1609 | - |
dc.citation.title | Journal of Korean Medical Science | - |
dc.citation.volume | 29 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1604 | - |
dc.citation.endPage | 1609 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001935453 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES | - |
dc.subject.keywordPlus | TRANSGENIC MICE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | SCRAPIE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | PROPAGATION | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | PRP | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | AGGREGATION | - |
dc.subject.keywordAuthor | Prions | - |
dc.subject.keywordAuthor | Recombinant Prion Protein | - |
dc.subject.keywordAuthor | Aggregates | - |
dc.subject.keywordAuthor | Amyloid | - |
dc.subject.keywordAuthor | Infectivity | - |
dc.identifier.url | https://jkms.org/DOIx.php?id=10.3346/jkms.2014.29.12.1604 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.